Free Trial

AtriCure (ATRC) Competitors

AtriCure logo
$35.66 +0.89 (+2.56%)
Closing price 09/4/2025 04:00 PM Eastern
Extended Trading
$35.66 0.00 (0.00%)
As of 09/4/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ATRC vs. TFX, ITGR, ATEC, IART, OFIX, SRDX, ANGO, ARAY, RMTI, and RSLS

Should you be buying AtriCure stock or one of its competitors? The main competitors of AtriCure include Teleflex (TFX), Integer (ITGR), Alphatec (ATEC), Integra LifeSciences (IART), Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), and ReShape Lifesciences (RSLS). These companies are all part of the "health care equipment" industry.

AtriCure vs. Its Competitors

AtriCure (NASDAQ:ATRC) and Teleflex (NYSE:TFX) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership, earnings and profitability.

Teleflex has higher revenue and earnings than AtriCure. AtriCure is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AtriCure$465.31M3.81-$44.70M-$0.77-46.31
Teleflex$3.05B1.87$69.68M$4.2530.33

AtriCure currently has a consensus price target of $50.89, suggesting a potential upside of 42.71%. Teleflex has a consensus price target of $141.57, suggesting a potential upside of 9.82%. Given AtriCure's stronger consensus rating and higher possible upside, equities research analysts plainly believe AtriCure is more favorable than Teleflex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AtriCure
0 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
3.00
Teleflex
1 Sell rating(s)
8 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, AtriCure had 1 more articles in the media than Teleflex. MarketBeat recorded 10 mentions for AtriCure and 9 mentions for Teleflex. AtriCure's average media sentiment score of 1.73 beat Teleflex's score of 1.05 indicating that AtriCure is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AtriCure
10 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Teleflex
6 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

AtriCure has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500. Comparatively, Teleflex has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.

Teleflex has a net margin of 6.31% compared to AtriCure's net margin of -7.27%. Teleflex's return on equity of 15.08% beat AtriCure's return on equity.

Company Net Margins Return on Equity Return on Assets
AtriCure-7.27% -4.20% -3.19%
Teleflex 6.31%15.08%8.85%

99.1% of AtriCure shares are held by institutional investors. Comparatively, 95.6% of Teleflex shares are held by institutional investors. 3.5% of AtriCure shares are held by company insiders. Comparatively, 1.4% of Teleflex shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

AtriCure beats Teleflex on 9 of the 16 factors compared between the two stocks.

Get AtriCure News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ATRC vs. The Competition

MetricAtriCureMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.73B$10.94B$5.76B$9.85B
Dividend YieldN/A1.85%6.67%4.51%
P/E Ratio-46.3121.6875.7526.43
Price / Sales3.8131.25547.78119.09
Price / CashN/A24.5637.0558.92
Price / Book3.773.5711.156.06
Net Income-$44.70M$212.34M$3.29B$266.28M
7 Day Performance-3.60%-2.90%0.20%-0.32%
1 Month Performance-5.01%7.70%6.30%3.44%
1 Year Performance36.42%-8.61%54.81%23.11%

AtriCure Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ATRC
AtriCure
3.7809 of 5 stars
$35.66
+2.6%
$50.89
+42.7%
+36.1%$1.73B$465.31M-46.311,300Positive News
TFX
Teleflex
4.2867 of 5 stars
$126.58
+0.3%
$141.57
+11.8%
-47.4%$5.59B$3.05B29.7814,100Positive News
ITGR
Integer
4.1908 of 5 stars
$107.58
+0.2%
$140.25
+30.4%
-16.7%$3.78B$1.72B47.3911,000Positive News
ATEC
Alphatec
3.9154 of 5 stars
$15.90
-0.8%
$18.50
+16.4%
+145.2%$2.35B$611.56M-14.07700News Coverage
Positive News
Insider Trade
IART
Integra LifeSciences
3.7594 of 5 stars
$15.13
+2.0%
$18.43
+21.8%
-19.0%$1.18B$1.61B-2.324,396Positive News
OFIX
Orthofix Medical
3.3907 of 5 stars
$14.98
+1.6%
$21.50
+43.5%
-11.4%$591.62M$799.49M-4.731,616News Coverage
Positive News
SRDX
Surmodics
4.4696 of 5 stars
$34.04
-0.8%
$43.00
+26.3%
-14.0%$486.69M$126.08M-27.67450Positive News
ANGO
AngioDynamics
4.323 of 5 stars
$10.26
+1.3%
$19.00
+85.2%
+46.4%$416.90M$292.50M-12.36760Positive News
ARAY
Accuray
4.6916 of 5 stars
$1.52
-2.6%
$5.00
+228.9%
-25.2%$171.27M$458.51M-76.001,040
RMTI
Rockwell Medical
3.8753 of 5 stars
$1.71
-5.0%
$4.00
+133.9%
-46.3%$58.88M$101.49M-28.50300Short Interest ↑
High Trading Volume
RSLS
ReShape Lifesciences
0.0159 of 5 stars
$3.16
-1.4%
N/A-99.6%$8.49M$8.01M-0.0350Positive News
Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:ATRC) was last updated on 9/5/2025 by MarketBeat.com Staff
From Our Partners